. Author manuscript; available in PMC: 2014 Dec 1.

Published in final edited form as: Mol Cancer Ther. 2013 Oct 15;12(12):10.1158/1535-7163.MCT-13-0547. doi: 10.1158/1535-7163.MCT-13-0547

Table 2.

Odds ratios of the combined cohorts depicting OS at 5 and 10 years in the PA/ErbB2 High vs. PA/ErbB2 Low groups.

OS, y	No. of patients	PA/ErbB2 High (%)	PA/ErbB2 Low (%)	Odds Ratio (95% CI)	P
<5	192	60	40	2.68 (1.68 – 4.28)	<0.0001
>5	123	36	64	2.68 (1.68 – 4.28)	<0.0001
<10	213	60	40	2.76 (1.80 – 4.25)	<0.0001
>10	153	35	65	2.76 (1.80 – 4.25)	<0.0001